CRISPR

CRISPR1-fabp2

ID
ZDB-CRISPR-200413-1
Name
CRISPR1-fabp2
Previous Names
None
Target
Sequence
5' - ACAGTCAGGACTATCGTTAA - 3'
Disclaimer
Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.
Note
None
Genome Resources
None
Target Location
Constructs
No data available
Genomic Features
Genomic Feature Affected Genomic Regions
zf3195 fabp2
Expression
Gene expression in Wild Types + CRISPR1-fabp2
No data available
Phenotype
Phenotype resulting from CRISPR1-fabp2
No data available
Phenotype of all Fish created by or utilizing CRISPR1-fabp2
Phenotype Fish Conditions Figures
intestine cpt1aa expression decreased amount, abnormal fabp2zf3195/zf3195 (AB) standard conditions Fig. 4 from Zhao et al., 2020
intestine acat1 expression decreased amount, abnormal fabp2zf3195/zf3195 (AB) standard conditions Fig. 4 from Zhao et al., 2020
intestine all-cis-5,8,11,14,17-icosapentaenoic acid decreased amount, abnormal fabp2zf3195/zf3195 (AB) standard conditions Fig. 2 from Zhao et al., 2020
intestine agpat2 expression increased amount, abnormal fabp2zf3195/zf3195 (AB) standard conditions Fig. 4 from Zhao et al., 2020
liver pparg expression increased amount, abnormal fabp2zf3195/zf3195 (AB) standard conditions Fig. 4 from Zhao et al., 2020
liver low-density lipoprotein cholesterol increased amount, abnormal fabp2zf3195/zf3195 (AB) standard conditions Fig. 2 from Zhao et al., 2020
intestine got2a expression decreased amount, abnormal fabp2zf3195/zf3195 (AB) standard conditions Fig. 4 from Zhao et al., 2020
intestine triglyceride increased amount, abnormal fabp2zf3195/zf3195 (AB) standard conditions Fig. 2 from Zhao et al., 2020
intestine all-cis-docosa-4,7,10,13,16,19-hexaenoic acid decreased amount, abnormal fabp2zf3195/zf3195 (AB) standard conditions Fig. 2 from Zhao et al., 2020
blood plasma triglyceride increased amount, abnormal fabp2zf3195/zf3195 (AB) standard conditions Fig. 2 from Zhao et al., 2020
intestine slc27a4 expression decreased amount, abnormal fabp2zf3195/zf3195 (AB) standard conditions Fig. 4 from Zhao et al., 2020
liver pparaa expression increased amount, abnormal fabp2zf3195/zf3195 (AB) standard conditions Fig. 4 from Zhao et al., 2020
intestine fatty acid composition, abnormal fabp2zf3195/zf3195 (AB) standard conditions Fig. 2 from Zhao et al., 2020
intestine saturated fatty acid increased amount, abnormal fabp2zf3195/zf3195 (AB) standard conditions Fig. 2 from Zhao et al., 2020
intestine ldlra expression increased amount, abnormal fabp2zf3195/zf3195 (AB) standard conditions Fig. 4 from Zhao et al., 2020
intestine fabp1a expression increased amount, abnormal fabp2zf3195/zf3195 (AB) standard conditions Fig. 4 from Zhao et al., 2020
liver phosphatidylinositol increased amount, abnormal fabp2zf3195/zf3195 (AB) standard conditions Fig. 2 from Zhao et al., 2020
blood plasma low-density lipoprotein cholesterol increased amount, abnormal fabp2zf3195/zf3195 (AB) standard conditions Fig. 2 from Zhao et al., 2020
intestine abca1a expression decreased amount, abnormal fabp2zf3195/zf3195 (AB) standard conditions Fig. 4 from Zhao et al., 2020
liver cholesteryl ester increased amount, abnormal fabp2zf3195/zf3195 (AB) standard conditions Fig. 2 from Zhao et al., 2020
liver increased accumulation hepatocyte fatty acid, abnormal fabp2zf3195/zf3195 (AB) standard conditions Fig. 2 from Zhao et al., 2020
intestine dgat2 expression increased amount, abnormal fabp2zf3195/zf3195 (AB) standard conditions Fig. 4 from Zhao et al., 2020
liver high-density lipoprotein cholesterol increased amount, abnormal fabp2zf3195/zf3195 (AB) standard conditions Fig. 2 from Zhao et al., 2020
intestine cd36 expression decreased amount, abnormal fabp2zf3195/zf3195 (AB) standard conditions Fig. 4 from Zhao et al., 2020
liver triglyceride increased amount, abnormal fabp2zf3195/zf3195 (AB) standard conditions Fig. 2 from Zhao et al., 2020
intestine hmgcra expression increased amount, abnormal fabp2zf3195/zf3195 (AB) standard conditions Fig. 4 from Zhao et al., 2020
intestine abca1b expression decreased amount, abnormal fabp2zf3195/zf3195 (AB) standard conditions Fig. 4 from Zhao et al., 2020
liver srebf1 expression increased amount, abnormal fabp2zf3195/zf3195 (AB) standard conditions Fig. 4 from Zhao et al., 2020
Citations